|
Volumn 181, Issue 5, 2001, Pages 440-444
|
Does neoadjuvant chemoradiation downstage esophageal carcinoma?
a a a a a |
Author keywords
Chemoradiotherapy; Esophageal carcinoma
|
Indexed keywords
CISPLATIN;
FLUOROURACIL;
ADULT;
AGED;
ARTICLE;
BLEEDING;
CANCER ADJUVANT THERAPY;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CONTROLLED STUDY;
ESOPHAGUS CARCINOMA;
ESOPHAGUS RESECTION;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
LENGTH OF STAY;
MAJOR CLINICAL STUDY;
MALE;
OPERATION DURATION;
PREDICTION;
PRIORITY JOURNAL;
SURGICAL RISK;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
COMBINED MODALITY THERAPY;
ENDOSONOGRAPHY;
ESOPHAGEAL NEOPLASMS;
FEMALE;
FLUOROURACIL;
HUMANS;
MALE;
MIDDLE AGED;
NEOADJUVANT THERAPY;
NEOPLASM STAGING;
PREDICTIVE VALUE OF TESTS;
PREOPERATIVE CARE;
PROGNOSIS;
RADIOTHERAPY, ADJUVANT;
RETROSPECTIVE STUDIES;
SENSITIVITY AND SPECIFICITY;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 0034969442
PISSN: 00029610
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9610(01)00601-8 Document Type: Article |
Times cited : (48)
|
References (26)
|